AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19045962 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-solving treatment for primary care (PST-PC)
Number of subjects: 151
Study 19045962 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 151
Study 20139785 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent exercise at 85% of VO(2peak)
Number of subjects: 18
Study 20139785 — intervention group
Group type: COMPARATOR
Intervention: Intermittent exercise at 70% of VO(2peak)
Number of subjects: 18
Study 20139785 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent exercise at 85% of VO(2peak) (trained subjects only)
Number of subjects: 18
Study 20139785 — intervention group
Group type: COMPARATOR
Intervention: All exercise trials
Number of subjects: 18
Study 16286102 — intervention group
Group type: EXPERIMENTAL
Intervention: Pathway Access Sheath (PAS)
Number of subjects: 21
Study 16286102 — intervention group
Group type: COMPARATOR
Intervention: High-pressure balloon catheter (control)
Number of subjects: 21
Study 11483173 — intervention group
Group type: EXPERIMENTAL
Intervention: College students faced with hypothetical discount cards for supermarkets
Number of subjects: 0
Study 11483173 — intervention group
Group type: COMPARATOR
Intervention: Older adults faced with hypothetical discount cards for supermarkets
Number of subjects: 0
Study 9593008 — intervention group
Group type: EXPERIMENTAL
Intervention: ALVAC-gp160/rgp120
Number of subjects: 0
Study 9593008 — intervention group
Group type: COMPARATOR
Intervention: ALVAC-gp160
Number of subjects: 0
Study 9593008 — intervention group
Group type: COMPARATOR
Intervention: rgp120
Number of subjects: 0
Study 8162979 — intervention group
Group type: EXPERIMENTAL
Intervention: Home rehabilitation programme for 12 weeks, including physiotherapy and supervision by a nurse and general practitioner
Number of subjects: 43
Study 8162979 — intervention group
Group type: EXPERIMENTAL
Intervention: Home rehabilitation programme for 12 weeks
Number of subjects: 43
Study 8162979 — intervention group
Group type: COMPARATOR
Intervention: Control group (15 patients, no rehabilitation)
Number of subjects: 43
Study 3074776 — intervention group
Group type: EXPERIMENTAL
Intervention: Redivac suction drain
Number of subjects: 0
Study 3074776 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous corrugated drains
Number of subjects: 0
Study 3074776 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative pyrexia (three degrees examined)
Number of subjects: 0
Study 3074776 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of amnion rupture and number of vaginal examinations
Number of subjects: 0
Study 31796304 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil 1μg.kg‐1 bolus + 0.15μg.kg‐1.min‐1 infusion (stopped after skin incision)
Number of subjects: 51
Study 31796304 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil 1μg.kg‐1 bolus
Number of subjects: 51
Study 31796304 — intervention group
Group type: COMPARATOR
Intervention: Control group (no remifentanil until delivery)
Number of subjects: 51
Study 29932460 — intervention group
Group type: EXPERIMENTAL
Intervention: Year-long vegetable gardening intervention
Number of subjects: 0
Study 26818407 — intervention group
Group type: EXPERIMENTAL
Intervention: TAU plus brief CBT-based intervention
Number of subjects: 50
Study 26818407 — intervention group
Group type: COMPARATOR
Intervention: TAU (control group)
Number of subjects: 50
Study 23760975 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti‐Stigma Project workshop
Number of subjects: 258
Study 22264146 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic instruction
Number of subjects: 29
Study 22264146 — intervention group
Group type: COMPARATOR
Intervention: Conventional instruction (trial-and-error learning)
Number of subjects: 29
Study 18722608 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiologic oxygen concentration (6% CO(2) + 5% O(2) + 89% N(2)) throughout culture period
Number of subjects: 0
Study 18722608 — intervention group
Group type: COMPARATOR
Intervention: Atmospheric condition (6% CO(2) in air) until day 3, then physiologic environment
Number of subjects: 0
Study 19087756 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage therapy (10 sessions)
Number of subjects: 100
Study 19087756 — intervention group
Group type: COMPARATOR
Intervention: Control sessions
Number of subjects: 100
Study 19087756 — intervention group
Group type: COMPARATOR
Intervention: Massage therapy and Control
Number of subjects: 100
Study 15631314 — intervention group
Group type: EXPERIMENTAL
Intervention: Duodenum preserving pancreatic head resection (Beger technique and its variations)
Number of subjects: 0
Study 15631314 — intervention group
Group type: COMPARATOR
Intervention: Radical techniques (Whipple procedure)
Number of subjects: 0
Study 11762564 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam oral syrup administration
Number of subjects: 87
Study 11762564 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam intravenous administration
Number of subjects: 87
Study 11762564 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam bioavailability
Number of subjects: 87
Study 11762564 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial oral dose of midazolam
Number of subjects: 87
Study 9567248 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfamethoxazole/trimethoprim plus norfloxacin (ST + NFLX)
Number of subjects: 75
Study 9567248 — intervention group
Group type: COMPARATOR
Intervention: Sulfamethoxazole/trimethoprim alone (ST)
Number of subjects: 75
Study 8149521 — intervention group
Group type: EXPERIMENTAL
Intervention: Hirudin (0.05, 0.10, 0.20, or 0.30 mg.kg‐1.h‐1 infusion)
Number of subjects: 166
Study 8149521 — intervention group
Group type: EXPERIMENTAL
Intervention: Hirudin
Number of subjects: 166
Study 8149521 — intervention group
Group type: COMPARATOR
Intervention: Heparin (target aPTT of 65 to 90 or 90 to 110 seconds)
Number of subjects: 166
Study 3144979 — intervention group
Group type: EXPERIMENTAL
Intervention: Astemizole
Number of subjects: 109
Study 3144979 — intervention group
Group type: COMPARATOR
Intervention: Terfenadine
Number of subjects: 109
Study 29475875 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultra-conservative ICD programming strategy
Number of subjects: 83
Study 29475875 — intervention group
Group type: COMPARATOR
Intervention: Standard ICD programming by treating physician
Number of subjects: 83
Study 29475875 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT ON
Number of subjects: 83
Study 29475875 — intervention group
Group type: COMPARATOR
Intervention: CRT OFF
Number of subjects: 83
Study 26041582 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 53
Study 25727080 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based walking program
Number of subjects: 86
Study 25727080 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 86
Study 23446823 — intervention group
Group type: COMPARATOR
Intervention: Cefazolin alone (control arm)
Number of subjects: 130
Study 23446823 — intervention group
Group type: EXPERIMENTAL
Intervention: Vancomycin and cefazolin (experimental arm)
Number of subjects: 130
Study 23446823 — intervention group
Group type: EXPERIMENTAL
Intervention: MRSA carriers
Number of subjects: 130
Study 23446823 — intervention group
Group type: EXPERIMENTAL
Intervention: Noncarriers
Number of subjects: 130
Study 21035063 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine treatment
Number of subjects: 233
Study 21035063 — intervention group
Group type: COMPARATOR
Intervention: Patching treatment
Number of subjects: 233
Study 18218314 — intervention group
Group type: EXPERIMENTAL
Intervention: Nocturnal home hemodialysis (NHD)
Number of subjects: 32
Study 18218314 — intervention group
Group type: COMPARATOR
Intervention: Conventional hemodialysis (CHD)
Number of subjects: 32
Study 16343769 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurofeedback training (NFT) in the Experimental (EXP) group (15 children)
Number of subjects: 20
Study 16343769 — intervention group
Group type: COMPARATOR
Intervention: No neurofeedback training in the Control (CON) group (5 children)
Number of subjects: 20
Study 12180720 — intervention group
Group type: EXPERIMENTAL
Intervention: etoricoxib 90 mg once daily
Number of subjects: 816
Study 12180720 — intervention group
Group type: EXPERIMENTAL
Intervention: naproxen 500 mg twice daily
Number of subjects: 816
Study 12180720 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 816
Study 10343582 — intervention group
Group type: EXPERIMENTAL
Intervention: Neonatal repair
Number of subjects: 0
Study 10343582 — intervention group
Group type: COMPARATOR
Intervention: 3 month repair
Number of subjects: 0
Study 10343582 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (neonatal and 3 month repair)
Number of subjects: 0
Study 8942345 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal bupivacaine 2 mg h‐1 (n = 12)
Number of subjects: 47
Study 8942345 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal bupivacaine 1 mg h‐1 (n = 12)
Number of subjects: 47
Study 8942345 — intervention group
Group type: COMPARATOR
Intervention: Saline (n = 11)
Number of subjects: 47
Study 1959410 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP 5 for 1 hour
Number of subjects: 106
Study 1959410 — intervention group
Group type: COMPARATOR
Intervention: T-piece/ZEEP for 1 hour
Number of subjects: 106
Study 7261637 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening and intervention in high risk samples (HRS)
Number of subjects: 0
Study 7261637 — intervention group
Group type: COMPARATOR
Intervention: Control group (LRS) that did not enter the trial
Number of subjects: 0
Study 30611294 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual acupuncture
Number of subjects: 0
Study 30611294 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency electroacupuncture
Number of subjects: 0
Study 30611294 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency electroacupuncture
Number of subjects: 0
Study 28326321 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided deep cervical plexus block
Number of subjects: 56
Study 28326321 — intervention group
Group type: COMPARATOR
Intervention: Fluoroscopy-guided deep cervical plexus block
Number of subjects: 56
Study 25356799 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week home-based walking intervention
Number of subjects: 69
Study 25356799 — intervention group
Group type: COMPARATOR
Intervention: Nutrition education module (control)
Number of subjects: 69
Study 25222305 — intervention group
Group type: EXPERIMENTAL
Intervention: lopinavir/ritonavir (LPV/r)-based ART
Number of subjects: 0
Study 25222305 — intervention group
Group type: COMPARATOR
Intervention: nevirapine (NVP)-based ART
Number of subjects: 0
Study 25222305 — intervention group
Group type: COMPARATOR
Intervention: NVP-based ART
Number of subjects: 0
Study 22705118 — intervention group
Group type: EXPERIMENTAL
Intervention: Biweekly combination therapy with gemcitabine (1000 mg/m²) and carboplatin (AUC 3) on days 1 and 15, every 4 weeks
Number of subjects: 61
Study 22705118 — intervention group
Group type: COMPARATOR
Intervention: Gemcitabine monotherapy (1000 mg/m²) on days 1, 8, and 15, every 4 weeks
Number of subjects: 61
Study 19948934 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention for prevention of depression
Number of subjects: 900
Study 19948934 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgroup analysis (women and those with higher depression scores)
Number of subjects: 900
Study 17369082 — intervention group
Group type: EXPERIMENTAL
Intervention: Valacyclovir 3g/day for 14 days
Number of subjects: 20
Study 17369082 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 20
Study 15337871 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-D computed tomography (MMS CT)
Number of subjects: 5
Study 15337871 — intervention group
Group type: COMPARATOR
Intervention: Axial computed tomography (Axial CT)
Number of subjects: 5
Study 11349793 — intervention group
Group type: EXPERIMENTAL
Intervention: Local pulsated pressure treatment
Number of subjects: 35
Study 11349793 — intervention group
Group type: COMPARATOR
Intervention: Gentamicin treatment
Number of subjects: 35
Study 10443310 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-GPIIb/IIIa molecules
Number of subjects: 0
Study 10443310 — intervention group
Group type: COMPARATOR
Intervention: Classical anti-aggregant drugs
Number of subjects: 0
Study 7788006 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceruloplasmin measurement in patients with NIDDM
Number of subjects: 0
Study 7788006 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 0
Study 2085099 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast-feeding
Number of subjects: 0
Study 2085099 — intervention group
Group type: COMPARATOR
Intervention: Low protein formula (1.1 g/100 ml)
Number of subjects: 0
Study 2085099 — intervention group
Group type: COMPARATOR
Intervention: Conventional protein formula (1.5 g/100 ml)
Number of subjects: 0
Study 2085099 — intervention group
Group type: COMPARATOR
Intervention: Formula-fed groups (both low and conventional protein)
Number of subjects: 0
Study 377971 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefazolin, 1.0 gm administered intramuscularly and cephalothin, 2.0 gm administered intravenously at 6, 12, and 24 hours postoperatively
Number of subjects: 95
Study 377971 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study 31541292 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted training modules (5 modules including postural stability, mobilisation of lower extremity joints, leg and trunk stabilisation, jumping and landing exercises, agility movements)
Number of subjects: 1130
Study 31541292 — intervention group
Group type: COMPARATOR
Intervention: Standard programme (control group)
Number of subjects: 1130
Study 29806081 — intervention group
Group type: EXPERIMENTAL
Intervention: Docosahexaenoic acid, choline, and uridine‐5‐monophosphate supplementation
Number of subjects: 62
Study 29806081 — intervention group
Group type: COMPARATOR
Intervention: Control group (no supplementation)
Number of subjects: 62
Study 27046159 — intervention group
Group type: EXPERIMENTAL
Intervention: Continued thienopyridine and aspirin after 12 months
Number of subjects: 0
Study 27046159 — intervention group
Group type: EXPERIMENTAL
Intervention: DAPT score ≥2 with continued thienopyridine
Number of subjects: 0
Study 27046159 — intervention group
Group type: EXPERIMENTAL
Intervention: DAPT score <2 with continued thienopyridine
Number of subjects: 0
Study 27046159 — intervention group
Group type: COMPARATOR
Intervention: Placebo and aspirin after 12 months
Number of subjects: 0
Study 24398718 — intervention group
Group type: EXPERIMENTAL
Intervention: Core stabilization exercise with real-time feedback for 30 minutes per day for 6 weeks
Number of subjects: 19
Study 24398718 — intervention group
Group type: COMPARATOR
Intervention: Core stabilization exercise (control group)
Number of subjects: 19
Study 24398718 — intervention group
Group type: EXPERIMENTAL
Intervention: Core stabilization exercise with real-time feedback
Number of subjects: 19
Study 23266537 — intervention group
Group type: EXPERIMENTAL
Intervention: u-Health services (telemonitoring and teleconsultation supplemented with home visits)
Number of subjects: 144
Study 19789859 — intervention group
Group type: EXPERIMENTAL
Intervention: Lighter group (0.79 kg bat)
Number of subjects: 30
Study 19789859 — intervention group
Group type: EXPERIMENTAL
Intervention: Heavier group (1.36 kg bat)
Number of subjects: 30
Study 19789859 — intervention group
Group type: COMPARATOR
Intervention: Standard group (1.08 kg bat)
Number of subjects: 30
Study 19789859 — intervention group
Group type: EXPERIMENTAL
Intervention: Batters switching from 0.79 kg to 1.08 kg bat
Number of subjects: 30
Study 18535192 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic participants
Number of subjects: 2364
Study 15990782 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster schedule (6-week)
Number of subjects: 239
Study 15990782 — intervention group
Group type: COMPARATOR
Intervention: Conventional schedule (12-week)
Number of subjects: 239
Study 12923146 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser zona drilling
Number of subjects: 128
Study 12923146 — intervention group
Group type: COMPARATOR
Intervention: Acid Tyrode medium zona drilling
Number of subjects: 128
Study 10337521 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous cervicothoracic epidural block (group A)
Number of subjects: 20
Study 10337521 — intervention group
Group type: COMPARATOR
Intervention: Stellate ganglion block (group B)
Number of subjects: 20
Study 8642166 — intervention group
Group type: EXPERIMENTAL
Intervention: SADAS
Number of subjects: 54
Study 8642166 — intervention group
Group type: EXPERIMENTAL
Intervention: SADAS cognitive subscale
Number of subjects: 54
Study 8642166 — intervention group
Group type: EXPERIMENTAL
Intervention: SADAS noncognitive subscale
Number of subjects: 54
Study 8642166 — intervention group
Group type: COMPARATOR
Intervention: ADAS
Number of subjects: 54
Study 1736084 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient education
Number of subjects: 302
Study 1736084 — intervention group
Group type: COMPARATOR
Intervention: Simple recommendation
Number of subjects: 302
Study 6863579 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 50 mg/day
Number of subjects: 26
Study 6863579 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiloride-hydrochlorothiazide 5/50 mg/day
Number of subjects: 26
Study 6863579 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol 20 mg/day
Number of subjects: 26
Study 6863579 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of timolol with hydrochlorothiazide
Number of subjects: 26
Study 6863579 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of timolol with amiloride-hydrochlorothiazide
Number of subjects: 26
Study 6863579 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 2889550 — intervention group
Group type: EXPERIMENTAL
Intervention: LN2974
Number of subjects: 10
Study 28986164 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone treatment in T2D subjects
Number of subjects: 0
Study 28986164 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin treatment in T2D subjects
Number of subjects: 0
Study 28986164 — intervention group
Group type: COMPARATOR
Intervention: Control group (T2D subjects before treatment)
Number of subjects: 0
Study 26753767 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 0
Study 26753767 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 0
Study 24127651 — intervention group
Group type: EXPERIMENTAL
Intervention: ticagrelor
Number of subjects: 18421
Study 24127651 — intervention group
Group type: COMPARATOR
Intervention: clopidogrel
Number of subjects: 18421
Study 22356323 — intervention group
Group type: EXPERIMENTAL
Intervention: Colonoscopy
Number of subjects: 53202
Study 22356323 — intervention group
Group type: COMPARATOR
Intervention: Fecal immunochemical testing (FIT)
Number of subjects: 53202
Study 19629848 — intervention group
Group type: EXPERIMENTAL
Intervention: Prism adaptation (using 10 dioptre, 6 degree prisms)
Number of subjects: 37
Study 19629848 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment (using plain glasses)
Number of subjects: 37
Study 18517082 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual allergen immunotherapy (SLIT)
Number of subjects: 64
Study 18517082 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous allergen immunotherapy (SCIT)
Number of subjects: 64
Study 15855490 — intervention group
Group type: EXPERIMENTAL
Intervention: Didanosine (ddI) in addition to current combination therapy for 4 weeks
Number of subjects: 111
Study 15855490 — intervention group
Group type: EXPERIMENTAL
Intervention: Didanosine (ddI)
Number of subjects: 111
Study 14620660 — intervention group
Group type: EXPERIMENTAL
Intervention: Astropol polishing system
Number of subjects: 75
Study 14620660 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagloss polishing system
Number of subjects: 75
Study 14620660 — intervention group
Group type: EXPERIMENTAL
Intervention: Sof‐Lex polishing system
Number of subjects: 75
Study 10918432 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral granisetron (2 mg, 1 h before first daily fraction of radiation)
Number of subjects: 34
Study 10918432 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ondansetron (8 mg, 1.5 h prior to each fraction of TBI)
Number of subjects: 34
Study 10918432 — intervention group
Group type: COMPARATOR
Intervention: Historical control group (no 5-HT3-receptor antagonist)
Number of subjects: 34
Study 10918432 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral granisetron
Number of subjects: 34
Study 10918432 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ondansetron
Number of subjects: 34
Study 10918432 — intervention group
Group type: COMPARATOR
Intervention: Historical control group
Number of subjects: 34
Study 8781794 — intervention group
Group type: EXPERIMENTAL
Intervention: One-Action Stent Insertion System (OASIS)
Number of subjects: 20
Study 8781794 — intervention group
Group type: COMPARATOR
Intervention: Conventional delivery system
Number of subjects: 20
Study 1729516 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 0
Study 1729516 — intervention group
Group type: COMPARATOR
Intervention: Avafortan
Number of subjects: 0
Study 6743606 — intervention group
Group type: EXPERIMENTAL
Intervention: External cephalic version under tocolysis with intravenous ritodrine
Number of subjects: 130
Study 6743606 — intervention group
Group type: COMPARATOR
Intervention: Control group (no version attempted)
Number of subjects: 130
Study 31568714 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg of XEN1101
Number of subjects: 20
Study 30047347 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased consumption of sugars from sugar-sweetened beverages
Number of subjects: 22720
Study 30047347 — intervention group
Group type: EXPERIMENTAL
Intervention: Consumption of sugars from fruit juices or dessert foods
Number of subjects: 22720
Study 26723197 — intervention group
Group type: EXPERIMENTAL
Intervention: Foley catheter insertion with stylette
Number of subjects: 123
Study 26723197 — intervention group
Group type: COMPARATOR
Intervention: Foley catheter insertion without stylette
Number of subjects: 123
Study 24993981 — intervention group
Group type: EXPERIMENTAL
Intervention: Diuretics
Number of subjects: 2912
Study 24993981 — intervention group
Group type: EXPERIMENTAL
Intervention: High-ceiling sulphonamide diuretics
Number of subjects: 2912
Study 24993981 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication acting via the renin-angiotensin system
Number of subjects: 2912